- Presentations
- 2
- Markets
- 1
Tagrisso is a brand of Osimertinib marketed by AstraZeneca Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Osimertinib
- Brand owner
- AstraZeneca Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 40 mg tablet, 80 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Tagrisso 40 mg tabletOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Tagrisso 80 mg tabletOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Tagrisso
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.